RECRO PHARMA, INC.

RECRO PHARMA, INC.

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

Recro Pharma, Inc._logo

Industry:
Company

Address:
490 Lapp Road, Malvern, PA, United States Zipcode 19355

Country:
Germany

Phone:
484 395 2470

Company Size Range:
51 - 200
Current Employees:
78
Total Employees:
92

Market Cap:
70.10M
Total Revenue:
66.5M
Total Assets:
103.42M
Total Cash:
23.76M

Subsidiaries: Alkermes · Daravita Limited


Key Executives
Name Title Pay Year Born
Mr. Ryan D. Lake Chief Financial Officer 572,135$ 1977(43 years old)
Mr. J. David Enloe Jr. Pres, CEO & Director N/A 1964(56 years old)
Mr. William Hirschman VP of Sales & Marketing N/A N/A
Mr. Randall J. Mack Sr. VP of Devel. N/A 1965(55 years old)
Mr. Marshall Rizzo M.B.A. Sr. VP & Gen. Mang. N/A N/A
Mr. Richard Sidwell Ph.D. VP & Chief Scientific Officer N/A N/A
Ms. Carla Lusby Corp. Sec. N/A N/A



Financial & Stock
Company's stock symbol is RAH.SG. Lastest price : 2.1800. Total volume :500.00 Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.recropharma.com

  • Host name: 138.197.48.70
  • IP address: 138.197.48.70
  • Location: Clifton United States
  • Latitude: 40.8364
  • Longitude: -74.1403
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 07014

Loading ...
Loading ...


More informations about "Recro Pharma, Inc." on Search Engine

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com With an expertise in solving complex manufacturing problems, Recro is a CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical …

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com Safety and Opioid Use in Subjects of Advanced Age with Impaired Renal Function in a …

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com Nominating and Corporate Governance Committee Charter Download Nominating …

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com Quote :: Recro Pharma, Inc. (REPH). Skip to content. About. Leadership Team; Board of …

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com View all SEC Filings. View and filter by group or type. View All

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com Skip to content. About. Leadership Team; Board of Directors; Board Committees; …

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com SEC Filings - Investor Relations :: Recro Pharma, Inc. (REPH)

Investor Relations :: Recro Pharma, Inc. (REPH)

Ir.recropharma.com Dividend Distribution Letter :: Recro Pharma, Inc. (REPH)

Recro Pharma, Inc. (REPH) Stock Price, News, Quote

Finance.yahoo.com MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...

Recro Pharma, Inc. (REPH) Company Profile & Facts - Yahoo

Finance.yahoo.com Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and...

REPH Stock Price | Recro Pharma Inc. Stock Quote (U.S)

Marketwatch.com Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical...

Recro Announces Executive Changes - Recro Pharma, Inc.

Ir.recropharma.com Dec 16, 2020 · Recro is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage solid oral dose drug products.

Recro Pharma, Inc.

Ir.recropharma.com Recro Pharma, Inc. (the “Company”) was incorporated in Pennsylvania onNovember 15, 2007. The Company is a leading contract development and manufacturing organization (“CDMO”) with integrated solutions for formulation, analytical services, regulatory support, manufacturing, and …

Recro Announces Amendment to Athyrium - Recro Pharma, Inc.

Ir.recropharma.com MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the signing of an amendment to its existing credit facility with funds managed by Athyrium Capital …

Recro Pharma Receives Complete Response Letter from the

Ir.recropharma.com Mar 22, 2019 · About Recro Pharma, Inc. Recro Pharma is a specialty pharmaceutical company that operates through two business divisions, an Acute Care, hospital product division and a revenue-generating contract development and manufacturing, or CDMO, division, located in Gainesville, GA.

Contract Development & Manufacturing | Recro

Recrocdmo.com Recro can help provide solutions for your development, clinical trials, and commercial product needs.

REPH Institutional Ownership - Recro Pharma Inc

Fintel.io 214 rows · Recro Pharma Inc (US:REPH) institutional ownership structure shows current positions in …

Recro Pharma Inc. - Company Profile - BCIQ

Bciq.biocentury.com Apr 06, 2019 · The next test of FDA’s thinking on outcomes and thresholds could be Recro Pharma Inc. ’s......inhibitor under FDA review to treat postoperative pain. The PDUFA date is March 24, 2019.

REPH | Recro Pharma Inc. Profile | MarketWatch

Marketwatch.com Mar 22, 2021 · Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical ...

Recro Pharma, Inc. Company Profile | Malvern, PA

Dnb.com Recro Pharma, Inc.* 30. Contacts. Reach the right people with access to detailed contact information. 3. Principals. See who the company's key decision makers are. 4. Corporate Relations. Get the big picture on a company's affiliates and who they do business with. 9. Close Industry Peers.

Recro Pharma, Inc. to Host Earnings Call - Yahoo

Finance.yahoo.com NEW YORK, NY / ACCESSWIRE / February 26, 2021 / Recro Pharma, Inc. (NASDAQ:REPH) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 26 ...

REPH:NASDAQ CM Stock Quote - Recro Pharma Inc - Bloomberg

Bloomberg.com Recro Pharma, Inc. is a specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Recro Pharma offers its products to...

Recro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020

Seekingalpha.com Recro Pharma, Inc. (NASDAQ:REPH) Q4 2020 Earnings Conference Call February 26, 2021, 08:00 ET Company Participants Stephanie Diaz - IR David Enloe - President, CEO & Director Ryan Lake...

Recro Strengthens Leadership Team - Recro Pharma, Inc.

Ir.recropharma.com Recro Pharma, Inc. (“Recro”; NASD: REPH) is a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing of oral, solid dose drug products.

Alberici v. Recro Pharma, Inc. | The Legal Intelligencer

Law.com Recro Pharma, Inc. Plaintiff's second amended complaint in this shareholder class action, which alleged that defendants concealed concerns about the efficacy and manufacturing quality control of a ...

Is Recro Pharma, Inc. (NASDAQ:REPH) Popular Amongst

Finance.yahoo.com Recro Pharma is a smaller company with a market capitalization of US$108m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that...

Recro Pharma, Inc. (REPH) Stock Historical Prices & Data

Finance.yahoo.com Discover historical prices for REPH stock on Yahoo Finance. View daily, weekly or monthly format back to when Recro Pharma, Inc. stock was issued.

Wall Street Pummels Recro Pharma Inc. (REPH) After Recent

Newsheater.com Dec 14, 2020 · Recro Pharma Inc. (NASDAQ:REPH) went up by 36.81% from its latest closing price compared to the recent 1-year high of $19.21. The company’s stock price has collected 29.04% of gains in the last five trading sessions. Press Release reported on 11/09/20 that Recro Reports Third Quarter 2020 Financial Results. Get the hottest stocks to trade every day before the market opens 100% free.

Recro Expands Development and Manufacturing Relationship

Ir.recropharma.com 2 days ago · Additional Contract Broadens and Further Strengthens Customer Product Portfolio. GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …

Recro Pharma, Inc. - REPH - Stock Price Today - Zacks

Zacks.com Apr 13, 2021 · Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing ...

Recro Pharma Inc (REPH) Quote - XNAS | Morningstar

Morningstar.com Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose ...

Recro Expands Development and Manufacturing Relationship

Globenewswire.com 1 day ago · GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to …

Recro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020

Seekingalpha.com Nov 10, 2020 · Recro Pharma, Inc. (NASDAQ:REPH) Q3 2020 Earnings Conference Call November 09, 2020, 08:00 ET Company Participants Claudia Styslinger - Argot Partners Geraldine Henwood - President, CEO...

Recro Pharma, Inc. (REPH) CEO Gerri Henwood on Q2 2020

Seekingalpha.com Aug 10, 2020 · Recro Pharma, Inc. (NASDAQ:REPH) Q2 2020 Earnings Conference Call August 10, 2020 8:00 AM ET Company Participants. Claudia Styslinger - Investor Relations. Gerri Henwood - President and Chief ...

Recro Pharma, Inc. 2020 Q4 - Results - Earnings Call

Seekingalpha.com Feb 26, 2021 · The following slide deck was published by Recro Pharma, Inc. in conjunction with their 2020 Q4 earnings call.

Recro Pharma Inc (REPH) Q1 2020 Earnings Call Transcript

Fool.com May 12, 2020 · Recro Pharma Inc (NASDAQ:REPH) Q1 2020 Earnings Call May 11, 2020, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Ladies and ...

REPH | Recro Pharma Inc. SEC Filings | MarketWatch

Marketwatch.com Apr 09, 2021 · Recro Pharma Inc. SEC filings breakout by MarketWatch. View the REPH U.S. Securities and Exchange Commission reporting information.

Should I buy Recro Pharma, Inc. (REPH) - Zacks

Zacks.com Apr 12, 2021 · Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing ...

Recro Pharma, Inc. DEF 14A Mar. 27, 2020 5:29 PM | Seeking

Seekingalpha.com We are pleased to invite you to attend Recro Pharma, Inc.’s, or Recro’s, or the Company’s, 2020 Annual Meeting of Shareholders, or Annual Meeting, which will be held at 9:00 a.m., Eastern ...

Recro Pharma, Inc. (Form: 8-K, Received: 01/04/2019 16:25:55)

Content.edgar-online.com Recro Pharma, Inc. (Exact name of registrant as specified in its charter) Pennsylvania 001-36329 26-1523233 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 490 Lapp Road, Malvern, Pennsylvania ...

Recro Pharma, Inc. (Form: 10-K, Received: 03/02/2018 17:41:45)

Content.edgar-online.com Recro Pharma, Inc. (Exact name of registrant as specified in its charter) Pennsylvania 26-1523233 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 490 Lapp Road, Malvern, Pennsylvania 19355 (Address of principal executive offices) ...

Recro Pharma, Inc. (REPH) Latest Stock News & Headlines

Finance.yahoo.com Get the latest Recro Pharma, Inc. (REPH) stock news and headlines to help you in your trading and investing decisions.

REPH Recro Pharma, Inc. Stock Quote - FINVIZ.com

Finviz.com Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008.

Recro Pharma, Inc. (Form: 8-K, Received: 03/11/2015 16:31:48)

Content.edgar-online.com On March 9, 2015, Recro Pharma, Inc. (the “ Company ”) announced that it has entered into a definitive agreement to acquire from Alkermes plc, a private limited company incorporated in Ireland (“ Alkermes ”), worldwide rights to meloxicam IV/IM (“ Meloxicam ”) and a contract manufacturing facility and formulation business, through ...

Recro Pharma Inc. Stock Price (REPH) | Barron's

Barrons.com View today's stock price, news and analysis for Recro Pharma Inc. (REPH). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Recro Pharma, Inc. (Form: 8-K, Received: 11/26/2019 16:55:09)

Content.edgar-online.com Agreements with Baudax Bio, Inc. On November 21, 2019, Recro Pharma, Inc. (“Recro” or the “Company”) completed the previously announced separation of its acute care business segment, and certain other assets and liabilities.The separation was effected by means of a distribution of all of the outstanding shares of common stock of its wholly-owned subsidiary Baudax Bio, Inc. (“Baudax ...

Recro Pharma, Inc. (Form: 8-K, Received: 11/20/2017 07:17:51)

Content.edgar-online.com Recro Pharma, Inc. (Exact name of registrant as specified in its charter) Pennsylvania 001-36329 26-1523233 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 490 Lapp Road, Malvern, Pennsylvania ...

Recro Pharma Inc., Author at Stock Hide Out

Stockhideout.com 2 days ago · GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the signing of additional agreements with an existing customer, Ensysce Biosciences, Inc ...

Recro Pharma, Inc. (REPH) Stock Price Today, Quote & News

Seekingalpha.com Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and ...

Recro Pharma, Inc 490 Lapp Rd Malvern, PA Pharmaceutical

Mapquest.com Recro Pharma, Inc 490 Lapp Rd Malvern PA 19355. Reviews (484) 395-2470 Website. Menu & Reservations Make Reservations . Order Online Tickets Tickets See Availability Directions {{::location.tagLine.value.text}} Sponsored Topics. Legal. Help Get directions, reviews and information for Recro Pharma, Inc in Malvern, PA. ...

Recro Pharma, Inc. (Form: 10-Q, Received: 11/08/2019 07:13:11)

Content.edgar-online.com Recro Pharma, Inc., or the Company, was incorporated in Pennsylvania on November 15, 2007. The Company is a pharma services and pharmaceutical company that operates through two business segments: a revenue-generating contract development and manufacturing, or CDMO, segment and an Acute Care segment.

REPH | Recro Pharma Inc. Company Profile & Executives - WSJ

Wsj.com Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical ...

Recro Pharma Inc (REPH) Q4 2019 Earnings Call Transcript

Fool.com Mar 04, 2020 · Recro Pharma Inc (NASDAQ:REPH) Q4 2019 Earnings Call Mar 4, 2020, 8:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good morning, and ...

Recro Pharma, Inc. (Form: 10-Q, Received: 05/09/2018 07:04:06)

Content.edgar-online.com Recro Pharma, Inc., or the Company, was incorporated in Pennsylvania on November 15, 2007. The Company is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating contract development and manufacturing, or CDMO division.